E
Xeris Biopharma Holdings, Inc. XERS
$3.18 $0.1053.42%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Good
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.96
Price History XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 4.61%
30-Day Total Return 31.95%
60-Day Total Return 70.97%
90-Day Total Return 88.17%
Year to Date Total Return 40.40%
1-Year Total Return 139.10%
2-Year Total Return 33.05%
3-Year Total Return --
5-Year Total Return --
52-Week High % Change -2.45%
52-Week Low % Change 181.42%
Price XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $3.26
52-Week Low Price $1.13
52-Week Low Price (Date) Mar 10, 2023
52-Week High Price (Date) Feb 15, 2024
Valuation XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap $439.24M
Enterprise Value 601.20M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.45
Earnings Per Share Growth -55.55%
Price/Earnings To Growth --
Price/Sales (TTM) 2.88
Price/Book (Q) 113.57
Enterprise Value/Revenue (TTM) 3.94
Price $3.18
Enterprise Value/EBITDA (TTM) -21.18
Enterprise Value/EBIT -14.76
Market Cap Category Small Cap
Dividends and Shares XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 138.060M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 844 445 5704
Address 180 North LaSalle Street Chicago, IL 60601
Website www.xerispharma.com
Country United States
Year Founded 2005
Profitability XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -26.68%
Profit Margin -40.47%
Management Effectiveness XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -8.07%
Return on Equity --
Income Statement XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) $152.67M
Total Revenue (TTM) $152.67M
Revenue Per Share $1.11
Gross Profit (TTM) $125.30M
EBITDA (TTM) -$28.39M
EBIT (TTM) -$40.74M
Net Income (TTM) -$61.80M
Net Income Avl. to Common (TTM) -$61.80M
Total Revenue Growth (Q YOY) 62.56%
Earnings Growth (Q YOY) 44.17%
EPS Diluted (TTM) -$0.45
EPS Diluted Growth (Q YOY) 45.02%
Balance Sheet XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) $65.98M
Cash Per Share (Q) $0.48
Total Current Assets (Q) $158.05M
Total Preferred Equity (Q) --
Total Equity (Q) $3.87M
Current Ratio (Q) 1.816
Book Value Per Share (Q) $0.03
Total Assets (Q) $327.78M
Total Current Liabilities (Q) $87.04M
Total Debt (Q) $227.94M
Total Liabilities (Q) $323.92M
Total Common Equity (Q) $3.87M
Cash Flow XERS - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -$11.70M
Cash from Financing (TTM) $48.78M
Net Change in Cash (TTM) -$33.54M
Levered Free Cash Flow (TTM) -$36.93M
Cash from Operations (TTM) -$70.61M
Weiss Ratings